Question: A study showed 118 instances of breast cancer among 3,033 mothers who used diethylstibestrol (DES), an estrogen-like substance formerly used to prevent miscarriage, compared with 80 cases in 3,033 unexposed women comprising a control group. At the 0.01 level of significance, was the incidence of cancer greater in the DES users?